GSK2647544 structure
|
Common Name | GSK2647544 | ||
|---|---|---|---|---|
| CAS Number | 1380426-95-8 | Molecular Weight | 502.87 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H18ClF3N4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK2647544GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages[1]. |
| Name | GSK2647544 |
|---|
| Description | GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H18ClF3N4O3 |
|---|---|
| Molecular Weight | 502.87 |
| InChIKey | DRACNSAQZFZUKW-UHFFFAOYSA-N |
| SMILES | O=c1[nH]c(OCCc2ccc(Oc3ccc(Cl)c(C(F)(F)F)c3)cc2)ncc1Cc1cncnc1 |